Cardurion Pharmaceuticals, Inc.
Clinical trials sponsored by Cardurion Pharmaceuticals, Inc., explained in plain language.
-
New heart failure drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested a drug called tovinontrine in 303 adults with chronic heart failure where the heart pumps normally but is stiff. The goal was to see if the drug lowers a key heart stress marker (NT-proBNP) compared to a placebo over 12 weeks. Participants had symptoms like shor…
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new drug called tovinontrine in 557 adults with chronic heart failure and reduced pumping ability. The goal was to see if the drug could safely lower a key heart stress marker (NT-proBNP) compared to a placebo over 12 weeks. Participants had heart failure symp…
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC